Population health and regional variations of disease burden in Japan, 1990–2015: a systematic subnational analysis for the Global Burden of Disease Study 2015

Abstract

SummaryBackgroundJapan has entered the era of super-ageing and advanced health transition, which is increasingly putting pressure on the sustainability of its health system. The level and pace of this health transition might vary across regions within Japan and concern is growing about increasing regional variations in disease burden. The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) provides a comprehensive, comparable framework. We used data from GBD 2015 with the aim to quantify the burden of disease and injuries, and to attribute risk factors in Japan at a subnational, prefecture-level.MethodsWe used data from GBD 2015 for 315 causes and 79 risk factors of death, disease, and injury incidence and prevalence to measure the burden of diseases and injuries in Japan and in the 47 Japanese prefectures from 1990 to 2015. We extracted data from GBD 2015 to assess mortality, causes of death, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), life expectancy, and healthy life expectancy (HALE) in Japan and its 47 prefectures. We split extracted data by prefecture and applied GBD methods to generate estimates of burden, and attributable burden due to known risk factors. We examined the prefecture-level relationships of common health system inputs (eg, health expenditure and workforces) to the GBD outputs in 2015 to address underlying determinants of regional health variations.FindingsLife expectancy at birth in Japan increased by 4·2 years from 79·0 years (95% uncertainty interval [UI] 79·0 to 79·0) to 83·2 years (83·1 to 83·2) between 1990 and 2015. However, the gaps between prefectures with the lowest and highest life expectancies and HALE have widened, from 2·5 to 3·1 years and from 2·3 to 2·7 years, respectively, from 1990 to 2015. Although overall age-standardised death rates decreased by 29·0% (28·7 to 29·3) from 1990 to 2015, the rates of mortality decline in this period substantially varied across the prefectures, ranging from −32·4% (−34·8 to −30·0) to −22·0% (−20·4 to −20·1). During the same time period, the rate of age-standardised DALYs was reduced overall by 19·8% (17·9 to 22·0). The reduction in rates of age-standardised YLDs was very small by 3·5% (2·6 to 4·3). The pace of reduction in mortality and DALYs in many leading causes has largely levelled off since 2005. Known risk factors accounted for 34·5% (32·4 to 36·9) of DALYs; the two leading behavioural risk factors were unhealthy diets and tobacco smoking in 2015. The common health system inputs were not associated with age-standardised death and DALY rates in 2015.InterpretationJapan has been successful overall in reducing mortality and disability from most major diseases. However, progress has slowed down and health variations between prefectures is growing. In view of the limited association between the prefecture-level health system inputs and health outcomes, the potential sources of regional variations, including subnational health system performance, urgently need ...

Does an extreme age (≥80 years) affect outcomes in patients after liver cancer surgery? A meta‐analysis

“…According to recent US Census Bureau estimates, residents aged 65 and over increased from 35.0 million (12.4%) in 2000 to 49.2 million (15.2%) in 2016 . In Japan, life expectancy at birth has increased by 4.2 years from 79.0 years in 1990 to 83.2 years in 2015 . Patients with an extreme age (≥80 years) are estimated to account for 3.9 and 7.7% of the total population by the year of 2020 and 2050, respectively, in the United States…”

Global, Regional, National, and Subnational Big Data to Inform Health Equity Research: Perspectives from the Global Burden of Disease Study 2017

“…Another finding of note is the sharp difference in DALYs due to mental disorders between the United States and its neighbors. [21][22][23][24][25][26] America, South Africa, Philippines, and Russia had more deaths from interpersonal violence than would be expected given their SDI. Conversely, countries in Africa with some notable exceptions (ie, South Africa, Namibia, and Lesotho) and parts of Asia had much lower deaths from violence than would be expected.…”

“…to examine disparities and empower health officials to address health equity. [21][22][23][24][25][26] GBD data could also be used to assess progress from 1990 and as prove the understanding of the issues impacting the burden of disease. For example, the Health Access and Quality of Care Index (HAQ) is based on 32 causes from which deaths should not occur in the presence of effective health care.…”

Limited alignment of publicly competitive disease funding with disease burden in Japan

“…DALY is the most comprehensive measure of population health to date, which considers both the death and disability associated with a given disease [16]. However, there has not been sufficient discussion in Japan on R&D prioritization based on disease burden, except for our previous studies [17].…”